Drug Profile
Factor VIII gene therapy - Corautus Genetics
Alternative Names: Factor VIII MAXIMUM-AD; MAX-AD Factor VIII gene therapyLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Baxter Healthcare Corporation; Corautus Genetics
- Class Blood coagulation factors; Coagulants
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haemophilia A